Matches in Nanopublications for { ?s ?p "[This specifically applies to children with severe congenital neutropenia who receive lifelong treatment with G-CSF and in which the high susceptibility to develop MDS and acute myeloid leukemia (AML) has now become a major clinical concern.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- assertion description "[This specifically applies to children with severe congenital neutropenia who receive lifelong treatment with G-CSF and in which the high susceptibility to develop MDS and acute myeloid leukemia (AML) has now become a major clinical concern.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This specifically applies to children with severe congenital neutropenia who receive lifelong treatment with G-CSF and in which the high susceptibility to develop MDS and acute myeloid leukemia (AML) has now become a major clinical concern.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This specifically applies to children with severe congenital neutropenia who receive lifelong treatment with G-CSF and in which the high susceptibility to develop MDS and acute myeloid leukemia (AML) has now become a major clinical concern.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This specifically applies to children with severe congenital neutropenia who receive lifelong treatment with G-CSF and in which the high susceptibility to develop MDS and acute myeloid leukemia (AML) has now become a major clinical concern.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP331935.RAduzzfMop_w0HoD0h9__8IbeOmjA-v7d737pC5WMyfvc130_assertion description "[This specifically applies to children with severe congenital neutropenia who receive lifelong treatment with G-CSF and in which the high susceptibility to develop MDS and acute myeloid leukemia (AML) has now become a major clinical concern.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP331935.RAduzzfMop_w0HoD0h9__8IbeOmjA-v7d737pC5WMyfvc130_provenance.
- NP800642.RAT_M7aJXV84Ai5pSWOxmLgVVMDJbG7i9ULdBFe7T8TKI130_assertion description "[This specifically applies to children with severe congenital neutropenia who receive lifelong treatment with G-CSF and in which the high susceptibility to develop MDS and acute myeloid leukemia (AML) has now become a major clinical concern.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800642.RAT_M7aJXV84Ai5pSWOxmLgVVMDJbG7i9ULdBFe7T8TKI130_provenance.
- NP331798.RAnLeiwKqphpB2LuDcCheFd6uFhHmhT9eJK9l4gHzeukc130_assertion description "[This specifically applies to children with severe congenital neutropenia who receive lifelong treatment with G-CSF and in which the high susceptibility to develop MDS and acute myeloid leukemia (AML) has now become a major clinical concern.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP331798.RAnLeiwKqphpB2LuDcCheFd6uFhHmhT9eJK9l4gHzeukc130_provenance.
- NP331704.RAx17KjsuEvtUS2hXiZhPFvCGl7upK3iF_HerpHSL43fM130_assertion description "[This specifically applies to children with severe congenital neutropenia who receive lifelong treatment with G-CSF and in which the high susceptibility to develop MDS and acute myeloid leukemia (AML) has now become a major clinical concern.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP331704.RAx17KjsuEvtUS2hXiZhPFvCGl7upK3iF_HerpHSL43fM130_provenance.
- NP332035.RA2rfxSfbSUD1fzShi4DXyZ041UWD_X2l-TFea-DY5ogU130_assertion description "[This specifically applies to children with severe congenital neutropenia who receive lifelong treatment with G-CSF and in which the high susceptibility to develop MDS and acute myeloid leukemia (AML) has now become a major clinical concern.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP332035.RA2rfxSfbSUD1fzShi4DXyZ041UWD_X2l-TFea-DY5ogU130_provenance.
- NP800643.RA_mNRgWtiQ0AgF7R7tiISioYRsIMGICyr8A0vXW84HrQ130_assertion description "[This specifically applies to children with severe congenital neutropenia who receive lifelong treatment with G-CSF and in which the high susceptibility to develop MDS and acute myeloid leukemia (AML) has now become a major clinical concern.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800643.RA_mNRgWtiQ0AgF7R7tiISioYRsIMGICyr8A0vXW84HrQ130_provenance.
- NP800646.RA-jkOTdzUGqHJOZpEWhBPnL11lDdPoBwGch0RCviY9Ig130_assertion description "[This specifically applies to children with severe congenital neutropenia who receive lifelong treatment with G-CSF and in which the high susceptibility to develop MDS and acute myeloid leukemia (AML) has now become a major clinical concern.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800646.RA-jkOTdzUGqHJOZpEWhBPnL11lDdPoBwGch0RCviY9Ig130_provenance.